RiaSTAP

DRUG4 trials

Sponsors

Duke University, Weill Medical College of Cornell University, Nicklaus Children's Hospital f/k/a Miami Children's Hospital, IRCCS Policlinico S. Donato

Conditions

AfibrinogenemiaBleedingBleeding DisordersCardiac DiseaseCoagulopathic BleedingCoagulopathyHypofibrinogenemiaSurgery

Phase 2

Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness

CompletedNCT05780125

IRCCS Policlinico S. DonatoBleeding, Cardiac Disease, Hypofibrinogenemia +2

Start: 2023-03-20End: 2024-02-06Updated: 2024-02-28

Phase 4

Open Label Use Of RiaStap During Aortic Reconstruction

CompletedNCT01300286

Duke UniversityCoagulopathic Bleeding

Start: 2010-12-31End: 2012-12-31Updated: 2014-12-25

Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

CompletedNCT02822599

Nicklaus Children's Hospital f/k/a Miami Children's HospitalAfibrinogenemia, Bleeding Disorders, Hypofibrinogenemia

Start: 2017-06-01End: 2020-12-24Updated: 2021-09-16

Unknown Phase

Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions

TerminatedNCT02540434

Weill Medical College of Cornell UniversityCoagulopathy

Start: 2015-10-31End: 2017-12-31Updated: 2019-01-15

Related Papers

A Randomized Pilot Trial Assessing the Role of Human Fibrinogen Concentrate in Decreasing Cryoprecipitate Use and Blood Loss in Infants Undergoing Cardiopulmonary Bypass.

2022-03-199 citations